Severe metabolic or mixed acidemia on intensive care unit admission: incidence, prognosis and administration of buffer therapy. a prospective, multiple-center study

"Acidemia" can be defined as the accumulation of protons in the plasma which results in a lower blood pH if secondary responses are overwhelmed. In critically ill patients, acidosis is often the result of a combination of single disorders occurring simultaneously that are commonly known collectively as "mixed acid-base disorders" [1‐6].

Although "severe acidemia" is not a universally accepted term, it usually indicates that plasma pH is lower than 7.20 [3, 7, 8]. Severe acidemia can be critical, especially when an extremely low pH develops quickly. Clinical manifestations of severe acidemia include cerebral edema, seizures, diaphragm dysfunction [9], decreased myocardial contractility, pulmonary vasoconstriction and systemic vasodilatation [3, 10, 11]. Acidemia is a potentially life-threatening condition, and previous studies have described the incidence and mechanisms of acidosis occurring in the ICU [1, 12, 13]. Surprisingly, however, these studies failed to focus specifically on severe acidemia. Furthermore, despite the fact that severe acidemia reflects a serious underlying disease that should be treated as soon as possible, the treatment of acidemia by itself with the administration of intravenous buffers remains controversial [7, 8, 14, 15]. Indeed, notwithstanding experts' opinions arguing against treatment with intravenous buffers except in dedicated situations (for example, massive digestive fluid loss during diarrhea or tubular acidosis) [16], 86% of polled US nephrologists indicated that they would prescribe buffers to treat lactic acidosis in patients with a targeted pH above 7.20 [8]. Moreover, the Surviving Sepsis Campaign suggests not treating lactic acidosis when the plasma pH level is above 7.15, but does not give any recommendations for cases where the plasma pH level is below this threshold [7]. To date there have been only two small, prospective, randomized crossover studies assessing the impact of sodium bicarbonate treatment for lactic acidosis on hemodynamic, acid-base and electrolyte changes [14, 15]. Both studies included 24 patients and could not address any difference in terms of morbidity and mortality with regard to whether the patients had first been treated with sodium bicarbonate.

Therefore, we had two aims in our study. First, we sought to describe the incidence of severely metabolic or mixed acidemia patients admitted to the ICU. Second, we wanted to describe the outcomes of patients who had been treated at the onset of acidemia (within the first 24 hours of ICU admission) with intravenous sodium bicarbonate compared with those who had not. We hypothesized that severe acidosis within the 24 first hours after ICU admission is an infrequent phenomenon but that its correction rather than its initial severity is associated with prognosis.

This prospective, multiple-center study was conducted during a thirteen-month period in five ICUs. In accordance with French law, informed consent was not mandatory, given that this observational study did not modify diagnostic or therapeutic strategies. This study was approved by the Montpellier University Hospital Institutional Review Board and followed the Strengthening the Reporting of Observational Studies in Epidemiology recommendations for reporting observational studies [17].

During the study period, 2, 550 patients were admitted to the five participating ICUs. Among those patients, 200 consecutive patients (8%) with severe acidemia (pH < 7.20) were screened. Among those 200 patients, 35 (18%) exhibited a single respiratory acidemia. Among those 35 patients, 12 died (34%) and they were not further analyzed. Ten patients admitted for ketoacidosis were discharged alive and were not further analyzed (Figure 1).

Next, 155 patients (6% of the 2, 550 screened patients) were eligible for the prognostic analysis. Their characteristics are presented in Table 1. Eighty-four patients (54%) were intubated upon ICU admission, and one hundred thirty-five (88%) were intubated within the first 24 hours of their stay. During their stay, 90% of all patients required mechanical ventilation and vasopressors, 31 (20%) required renal replacement therapy within the first 24 hours of admission and 89 (57%) died during their ICU stay. No difference in terms of diagnosis was observed between survivors and nonsurvivors (Table 1). Conversely, older age, higher SAPS II or SOFA score and vasopressor requirement within the first 24 hours of admission were associated with mortality (Table 1). Although admission pH and bicarbonatemia were similar regardless of intubation status, lactatemia was significantly lower in the nonintubated patients than in those who were intubated (4.1 ± 4.1 mmol/L vs 8.7 ± 6.1 mmol/L; P = 0.01).

Figures 2A to 2F show the daily evaluation of acid-base and lactate parameters according to ICU survival. On the acid-base parameters, lactatemia and anion gap upon ICU admission were higher in nonsurvivors than in survivors (Table 1 and Figures 2E and 2F). Interestingly, although pH, plasma bicarbonate level and base excess were similar between survivors and nonsurvivors upon ICU admission, plasma pH remained lower in nonsurvivors than in survivors during the first 48 hours of the ICU stay (Additional file 1, Figure S1). We also analyzed acid-base balance according to the use of renal replacement therapy within the first 48 hours after ICU admission. After exclusion of patients receiving sodium bicarbonate infusion, there was not any significant pH variation between day 1 and day 0 according to the prescription of renal replacement therapy. Indeed, pH variation was 0.15 ± 0.14 among the 27 patients on renal replacement therapy compared to 0.18 ± 0.17 among the 73 patients off renal replacement therapy.

Among the 155 included patients, 57 were treated symptomatically with sodium bicarbonate within the first 24 hours of their stay in the ICU (Table 2). No difference was observed between patients treated or not treated with sodium bicarbonate regarding ICU admission diagnosis, acidosis mechanism, severity score and necessity of vasopressors or mechanical ventilation. In logistic regression, base excess was the sole parameter associated with sodium bicarbonate administration (OR = 0.91, 95% CI = 0.85 to 0.97; P = 0.005). Among the 98 patients who were not treated with sodium bicarbonate within the 24 first hours of their ICU stay, 6 were finally treated after 24 hours and 3 of them died in the ICU.

Bicarbonate administration ranged from 5% of the patients in one ICU to 55% in another one, depending mostly on the center delivering treatment rather than on the acidemia mechanism. When used, the concentration of sodium bicarbonate was 3.5 ± 3.3 mmol/L within the first 24 hours and ranged from 250 ml of 1.4% solution to 4, 000 ml of 4.2% solution, with no statistical difference observed between survivors and nonsurvivors. The severity of acidemia was not associated with the frequency of sodium bicarbonate prescription, but lower plasma bicarbonate, base excess, PaCO₂ and higher corrected anion gap were associated with sodium bicarbonate administration (Table 2). The different outcome parameters were not different on the basis of early prescription of sodium bicarbonate (Table 2). Multivariate analysis showed that although plasma pH upon ICU admission was not a predictor of outcome, the persistence of a low plasma pH after 24 hours in the ICU was an independent risk factor for mortality in the ICU (Table 3). Additional details are provided in the Additional file 1.

The main results of this study can be summarized as follows. First, severe metabolic or mixed acidemia defined by a plasma pH level lower than 7.20 within the first 24 hours of ICU admission was observed in 6% of critically ill patients. Second, severe metabolic or mixed acidemia was associated with an ICU mortality rate of 57%. Third, as opposed to pH value, the rapidity of acidemia correction was associated with mortality. Fourth, sodium bicarbonate prescription within the first 24 hours of acidemia was heterogeneous, depending on the participating ICU, and was not associated with the patient's prognosis.

Several limitations of this study must be identified. First, we defined and classified severe acidemia on the basis of a pH value below 7.20, bicarbonate and base excess [3, 18, 19], and instead used the physiochemical classification developed by Stewart [1, 23]. We chose this strategy because of its widespread use and because it was the easiest way to screen patients [6, 24]. Moreover, our study could not demonstrate that acidemia per se rather than the underlying disease was the main independent predictive factor in patient outcome. Indeed, our study was an observational, multiple-center study which included all consecutive, heterogeneous patients according to their acid-base status and was not designed to specifically address the impact of sodium bicarbonate on outcome or to address the reasons for sodium bicarbonate prescription. We also could not assess whether very early sodium bicarbonate administration (within the first six hours of acidemia), a different load of buffer (high vs low dose) or administration modalities (slow vs rapid infusion and/or concentrated vs diluted bicarbonate) had any different effects on outcome. However, the present cohort may be used as a tool with which to design a future interventional, randomized study to examine the effects of buffers in severely acidotic critically ill patients.

Although acidosis is a common concern in critically ill patients, studies specifically assessing epidemiology and outcomes of severe acidemia are lacking. Indeed, to our knowledge, the current study is the first prospective, multiple-center investigation focused specifically on severe acidemia occurring in the ICU. Previous studies reported an incidence of acidemia ranging from 14% [18] to 42% [25], but most of the patients in these studies experienced moderate acidemia with a mean base excess of -3. In a large, single-center study of 851 patients for whom arterial lactate levels were evaluated [12], the incidence of metabolic acidosis (defined by a standard base excess below -2 mmol/L) was 64%. In the present study, the incidence of metabolic or mixed severe acidemia was 6% (Figure 1).

The patients included in our study had a mean plasma pH of 7.09 ± 0.11 upon ICU admission. Those patients were defined as critically ill on the basis of their SAPS II and SOFA severity scores and the high rate of vasopressor prescription and mechanical ventilation (Table 1). Renal replacement therapy was initiated in 20% of these patients within the first 24 hours of their ICU stay. More than 50% of the patients died in the ICU (Tables 1 and 2). Upon ICU admission, only lactatemia and corrected anion gap could predict mortality (Figure 2). At day 1, plasma pH, bicarbonate and base excess were lower in nonsurvivors than in survivors (Figure 2). Our results are similar to those reported in a study describing acid-base disorders in 60 septic shock patients, among whom the survivors recovered from metabolic acidemia with correction of unmeasured anions and lactate, whereas nonsurvivors failed to do so [5]. However, the authors in that study screened the patients according to the presence of septic shock rather than the presence and the severity of acid-base disorders and thus could not specifically assess the prognosis of acidotic patients [5]. Another trial included unselected patients and showed that a base excess below -4 mmol/L upon ICU admission was associated with mortality [25]. The association between base excess and mortality was magnified after 24 hours of intensive resuscitation, thus showing the importance of acid-base disorder correction clearance in the critically ill.

In our present study focused on severe metabolic and mixed acidemia, we report that, as opposed to the pH value upon ICU admission, the rapidity of pH recovery was associated with mortality (Table 3). Whether metabolic acidemia is an etiologic contributor to organ dysfunction or just a marker of illness has been debated. Recent findings demonstrate that severe metabolic acidemia is at least a contributory factor to organ dysfunction, favoring cardiac output decrease, arterial dilatation with hypotension, arrhythmia, altered oxygen delivery, respiratory muscle workload increase in spontaneously breathing patients, decreased ATP production and impairment of the immune response [3, 16]. Acidemia correction using the administration of a base, primarily in the form of sodium bicarbonate, has naturally become the mainstay of therapy [26, 27], but its use continues to generate intense debate [2, 28, 29]. In our study, we included patients with severe academia, and the prescription of sodium bicarbonate was heterogeneous between the participating ICUs and independent of the mechanism of academia, as shown by chloremia and corrected anion gap values upon ICU admission (Table 1). Lower PaCO₂, bicarbonatemia and base excess were associated with sodium bicarbonate prescription. Interestingly, our results are similar to those of a recent North American survey which reported that over 60% of intensivists and 80% of nephrologists would consider the use of buffer therapy for the treatment of lactic acidosis [8]. To our knowledge, that survey and our present study are the only investigations that describe the pattern of sodium bicarbonate prescription for severe acidemia in critically ill patients.

When prescribing sodium bicarbonate in the critically ill, the potential side effects of severe acidemia must be balanced with complications related to sodium bicarbonate itself. Indeed, sodium bicarbonate may also be associated with complications such as a transient drop in blood pressure and cardiac output and a decrease in ionized calcium, thus sensitizing the heart to abnormal electrical activity and subsequent arrhythmia [2, 3, 29]. Moreover, "paradoxical" intracellular acidosis may occur because generated CO₂ freely diffuses across the cell membrane [2, 3, 29, 30]. In addition, bicarbonate administration can be responsible for hypernatremia, volume overload, the release of proinflammatory cytokines [31] and apoptosis [29]. In the present study, administration of sodium bicarbonate within the first 24 hours of acidemia was not associated with outcome (Tables 2 and 3).

In 2011, there is no human study that has reported any beneficial or detrimental effects of sodium bicarbonate administration when treating patients with severe mixed or metabolic acidemia. Therefore, attention should be first directed toward correcting the underlying basis for the acidemia.

This study reports for the first time that severe metabolic or mixed acidemia, defined by plasma pH lower than 7.20, occurs within the first 24 hours in the ICU in 6% of critically ill patients. In our study, severe acidemia was associated with a high mortality rate, and, rather than the initial pH value, the rapidity of acidemia correction appeared to be a determinant of outcome. Sodium bicarbonate therapy administration was very heterogeneous between participating ICUs. Further studies are necessary to better assess the role of buffers in this subgroup of critically ill patients.